Статті в журналах з теми "Defibrotide"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Defibrotide".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Richardson, Paul G., Marta Palomo, Nancy A. Kernan, Gerhard C. Hildebrandt, Nelson Chao, and Enric Carreras. "The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae." Bone Marrow Transplantation 56, no. 12 (September 28, 2021): 2889–96. http://dx.doi.org/10.1038/s41409-021-01383-x.
Повний текст джерела&NA;. "Defibrotide." Reactions Weekly &NA;, no. 538 (February 1995): 7. http://dx.doi.org/10.2165/00128415-199505380-00024.
Повний текст джерелаPalmer, Katharine J., and Karen L. Goa. "Defibrotide." Drugs 45, no. 2 (February 1993): 259–94. http://dx.doi.org/10.2165/00003495-199345020-00007.
Повний текст джерела&NA;. "Defibrotide." Reactions Weekly &NA;, no. 1113 (August 2006): 9. http://dx.doi.org/10.2165/00128415-200611130-00028.
Повний текст джерелаCoccheri, Sergio, and Giovanna Biagi. "Defibrotide." Cardiovascular Drug Reviews 9, no. 2 (June 1991): 172–96. http://dx.doi.org/10.1111/j.1527-3466.1991.tb00410.x.
Повний текст джерелаMoore, Julie M., and John W. Avery. "Defibrotide." Arteriosclerosis, Thrombosis, and Vascular Biology 32, no. 3 (March 2012): 541–44. http://dx.doi.org/10.1161/atvbaha.111.242776.
Повний текст джерелаBaker, Danial E., and Kendra Demaris. "Defibrotide." Hospital Pharmacy 51, no. 10 (October 2016): 847–54. http://dx.doi.org/10.1310/hpj5110-847.
Повний текст джерелаTappe, William, Saurabh Aggarwal, Ozlem Topaloglu, and Massimo Iacobelli. "A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting." Clinical and Applied Thrombosis/Hemostasis 26 (January 1, 2020): 107602962093520. http://dx.doi.org/10.1177/1076029620935202.
Повний текст джерелаFareed, Jawed, Debra A. Hoppensteadt, Massimo Iacobelli, and Jeanine M. Walenga. "Defibrotide Does Not Cross-React with HIT Antibodies. Implications in the Management of HIT." Blood 108, no. 11 (November 16, 2006): 1054. http://dx.doi.org/10.1182/blood.v108.11.1054.1054.
Повний текст джерелаPark, Meerim, Hyeon Jin Park, Hyeon-Seok Eom, Jeong A. Park, Yeon Jung Lim, Jong Hyung Yoon, Hye Won Lee, Tak Yun, and Byung-Kiu Park. "Effects of Prophylactic Defibrotide for Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation." Blood 118, no. 21 (November 18, 2011): 4517. http://dx.doi.org/10.1182/blood.v118.21.4517.4517.
Повний текст джерелаFareed, Jawed, Debra Hoppensteadt, Omer Iqbal, Josephine Cunanan, Vinod Bansal, Schuharazad Abro, and Rakesh Wahi. "Defibrotide Interactions with Newer Oral Anticoagulants and Antithrombotic Agents." Blood 120, no. 21 (November 16, 2012): 3411. http://dx.doi.org/10.1182/blood.v120.21.3411.3411.
Повний текст джерелаFareed, Jawed, Adrian Sonevytsky, Omer Iqbal, Walter P. Jeske, Massimo Iacobelli, and Debra Hoppensteadt. "Inhibition of Heparinase I by Defibrotide with Potential Clinical Implications." Blood 108, no. 11 (November 16, 2006): 1626. http://dx.doi.org/10.1182/blood.v108.11.1626.1626.
Повний текст джерелаFareed, Jawed, Debra Hoppensteadt, Josephine Cunanan, Walter Jeske, Cafer Adiguzal, He Zhu, Cinara Echart, and Massimo Iacobelli. "Prolonged Administration of Defibrotide Is Non-Immunogenic in Rats and Dogs." Blood 114, no. 22 (November 20, 2009): 4180. http://dx.doi.org/10.1182/blood.v114.22.4180.4180.
Повний текст джерелаFareed, Jawed, Michael J. Moorman, Walter Jeske, and Debra Hoppensteadt. "Defibrotide Interaction With Newer Oral Anticoagulant and Antiplatelet Drugs." Blood 122, no. 21 (November 15, 2013): 4804. http://dx.doi.org/10.1182/blood.v122.21.4804.4804.
Повний текст джерелаFareed, Jawed, Omer Iqbal, Debra Hoppensteadt, Cafer Adiguzel, Massimo Iacobelli, and Jeanine M. Walenga. "Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins." Blood 112, no. 11 (November 16, 2008): 4086. http://dx.doi.org/10.1182/blood.v112.11.4086.4086.
Повний текст джерелаTappe, William, Saurabh Aggarwal, Ozlem Topaloglu, and Massimo Iacobelli. "A Meta-Analysis Evaluating the Risk of Bleeding-Related Adverse Events with Defibrotide Treatment." Blood 134, Supplement_1 (November 13, 2019): 2016. http://dx.doi.org/10.1182/blood-2019-123686.
Повний текст джерелаMaher, Kristin N., Xu Han, Keith B. Neeves, Marvin T. Nieman, and Jorge Di Paola. "Modulation of Thrombin-Induced Platelet Activation By Defibrotide." Blood 134, Supplement_1 (November 13, 2019): 3614. http://dx.doi.org/10.1182/blood-2019-125945.
Повний текст джерелаHasenkamp, Justin, Imme Conradi, Gerald Wulf, Wolfram Jung, Lorenz Truemper, and Bertram Glass. "Prevention of Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation Due to Defibrotide Prophylaxis." Blood 104, no. 11 (November 16, 2004): 1139. http://dx.doi.org/10.1182/blood.v104.11.1139.1139.
Повний текст джерелаRichardson, Paul G., Enric Carreras, Massimo Iacobelli, and Bijan Nejadnik. "The use of defibrotide in blood and marrow transplantation." Blood Advances 2, no. 12 (June 26, 2018): 1495–509. http://dx.doi.org/10.1182/bloodadvances.2017008375.
Повний текст джерелаTekgunduz, Emre, Seval Akpinar, Sinem Civriz Bozdag, Aysegul Tetik, Serife Kocubaba, Murat Cinarsoy, Gamze Durgun, et al. "Effectiveness of Defibrotide in the Prevention of VOD Among Patients Receiving Allogeneic Hematopoetic Cell Transplantation: A Retrospective Single Center Experience." Blood 120, no. 21 (November 16, 2012): 4508. http://dx.doi.org/10.1182/blood.v120.21.4508.4508.
Повний текст джерелаFareed, Jawed, Walter Jeske, Demetra Callas, Debra Hoppensteadt, and Jeanine Walenga. "Modulation of Endothelium by Heparin and Related Polyelectrolytes." Clinical and Applied Thrombosis/Hemostasis 2, no. 3 (July 1996): 200–208. http://dx.doi.org/10.1177/107602969600200310.
Повний текст джерелаMarubini, E., S. Coccheri, G. G. Nenci, and F. Violi. "Improvement of Walking Distance by Defibrotide in Patients with Intermittent Claudication." Thrombosis and Haemostasis 83, no. 05 (2000): 672–77. http://dx.doi.org/10.1055/s-0037-1613890.
Повний текст джерелаHale, Gregory A., Renee M. Madden, Kimberly A. Kasow, Joseph Woodard, Wing H. Leung, Raymond C. Barfield, Usman Yusuf, Edwin M. Horwitz, and Rupert Handgretinger. "High Dose Defibrotide as Therapy for Pediatric Patients with Veno-Occlusive Disease of the Liver." Blood 108, no. 11 (November 16, 2006): 2963. http://dx.doi.org/10.1182/blood.v108.11.2963.2963.
Повний текст джерелаMountfort, Katrina, Mohamad Mohty, and Elisabeth Wallhult. "Defibrotide – A New Treatment Approach for Severe Veno-occlusive Disease." European Oncology & Haematology 11, no. 1 (2015): 11. http://dx.doi.org/10.17925/eoh.2015.11.01.11.
Повний текст джерелаUygun, Vedat, Gulsun Tezcan, Volkan Hazar, and Akif Yesilipek. "Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease in Children." Blood 108, no. 11 (November 16, 2006): 5263. http://dx.doi.org/10.1182/blood.v108.11.5263.5263.
Повний текст джерелаRichardson, Paul G., Nancy A. Kernan, Stephan A. Grupp, Paul L. Martin, Robert J. Soiffer, Richard Martin, Alison L. Hannah, and Kathleen F. Villa. "Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival." Blood 124, no. 21 (December 6, 2014): 2469. http://dx.doi.org/10.1182/blood.v124.21.2469.2469.
Повний текст джерелаMarsili, M., P. Lorenzi, M. Librenti, L. Doni, C. Benassai, E. Martini, L. P. Fabbri, S. Cinotti, M. Morfini, and S. Boncinelli. "Defibrotide in Extracorporeal Circulation on Healthy Rabbits." International Journal of Artificial Organs 12, no. 12 (December 1989): 749–54. http://dx.doi.org/10.1177/039139888901201203.
Повний текст джерелаRuggieri, M., D. Vicini, P. Mirando, G. P. Franceschetti, C. Sali, G. L. Picchio, P. Marandola, and L. Cocilovo. "Physical treatment and physical-drugs treatment of induratio penis plastica: Orgotein versus defibrotide versus only physical treatment. Our experience." Urologia Journal 61, no. 4 (August 1994): 259–61. http://dx.doi.org/10.1177/039156039406100404.
Повний текст джерелаChalandon, Yves, Federico Simonetta, Carole Dantin, Aikaterini Koutsi, Anne-Claire Mamez, Yan Beauverd, Olga Tsopra, et al. "Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)." Blood 128, no. 22 (December 2, 2016): 2204. http://dx.doi.org/10.1182/blood.v128.22.2204.2204.
Повний текст джерелаEchart, Cinara L., Barbara Graziadio, Simona Somaini, Laura I. Ferro, Paul G. Richardson, Jawed Fareed, and Massimo Iacobelli. "The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity." Blood Coagulation & Fibrinolysis 20, no. 8 (December 2009): 627–34. http://dx.doi.org/10.1097/mbc.0b013e32832da1e3.
Повний текст джерелаPogliani, E. M., M. Salvatore, C. Fowst, R. Girardello, and C. Marelli. "Effects of a Defibrotide—Heparin Combination on Some Measures of Haemostasis in Healthy Volunteers." Journal of International Medical Research 17, no. 1 (January 1989): 36–40. http://dx.doi.org/10.1177/030006058901700105.
Повний текст джерелаCorbacioglu, Selim, Ansgar S. Schulz, Petr Sedlacek, Bernd Gruhn, Simone Cesaro, and Peter Bader. "Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplantation: Subanalysis Data from an Open-Label, Phase III, Randomized Trial." Blood 126, no. 23 (December 3, 2015): 4310. http://dx.doi.org/10.1182/blood.v126.23.4310.4310.
Повний текст джерелаFilimberti, E., S. Cinotti, M. Salvadori, M. Amato, G. Longo, M. Nazzari, and M. Morfini. "Hemodialysis with Defibrotide: Effects on Coagulation Parameters." International Journal of Artificial Organs 15, no. 10 (October 1992): 590–94. http://dx.doi.org/10.1177/039139889201501004.
Повний текст джерелаKong, Seom Gim, Je-Hwan Lee, Young Tak Lim, Ji Hyun Lee, Hyeon-Seok Eom, Hyewon Lee, Do Young Kim, et al. "Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide." Korean Journal of Internal Medicine 37, no. 1 (January 1, 2022): 179–89. http://dx.doi.org/10.3904/kjim.2021.178.
Повний текст джерелаLaurence, Jeffrey, and Sonia Elhadad. "Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies." Blood 134, Supplement_1 (November 13, 2019): 3676. http://dx.doi.org/10.1182/blood-2019-124158.
Повний текст джерелаBelcaro, G., and C. Marelli. "Treatment of Venous Lipodermatosclerosis and Ulceration in Venous Hypertension by Elastic Compression and Fibrinolytic Enhancement with Defibrotide." Phlebology: The Journal of Venous Disease 4, no. 2 (June 1989): 91–106. http://dx.doi.org/10.1177/026835558900400207.
Повний текст джерела&NA;. "Walk further with defibrotide." Inpharma Weekly &NA;, no. 814 (November 1991): 14. http://dx.doi.org/10.2165/00128413-199108140-00039.
Повний текст джерелаFERRARESSO, MARIANO, PAOLO RIGOTTI, STANISLAW M. STEPKOWSKI, TING-CHAO CHOU, and BARRY D. KAHAN. "IMMUNOSUPPRESSIVE EFFECTS OF DEFIBROTIDE." Transplantation 56, no. 4 (October 1993): 928–33. http://dx.doi.org/10.1097/00007890-199310000-00029.
Повний текст джерелаBerti, F., F. Magni, and G. Rossoni. "Cardiovascular pharmacology of defibrotide." Pharmacological Research Communications 20 (September 1988): 37. http://dx.doi.org/10.1016/s0031-6989(88)80167-x.
Повний текст джерелаArtesani, M. C. "Anaphylactic shock to defibrotide." Allergy 61, no. 8 (August 2006): 1022. http://dx.doi.org/10.1111/j.1398-9995.2006.01086.x.
Повний текст джерелаRichardson, Paul G., Angela R. Smith, Brandon M. Triplett, Nancy A. Kernan, Stephan A. Grupp, Sally Arai, Joseph H. Antin, et al. "Updated Results from a Large, Ongoing, Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease." Blood 124, no. 21 (December 6, 2014): 2470. http://dx.doi.org/10.1182/blood.v124.21.2470.2470.
Повний текст джерелаRichardson, Paul, Enric Carreras, Antonio Pagliuca, Robert Ryan, William Tappe, and Mohamad Mohty. "A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem Cell Transplant (HSCT)." Blood 132, Supplement 1 (November 29, 2018): 815. http://dx.doi.org/10.1182/blood-2018-99-113099.
Повний текст джерелаUnal, Emel, Nurdan Tacyildiz, Gulsan Yavuz, Handan Dincaslan, Gulsah Tanyildiz, Erol Ayyildiz, and Muhit Ozcan. "Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Autologous, Non-Purged Peripheral Stem Cell Transplantation for High Risk Neuroblastoma Patients." Blood 124, no. 21 (December 6, 2014): 5910. http://dx.doi.org/10.1182/blood.v124.21.5910.5910.
Повний текст джерелаMilone, G., M. Poidomani, S. Coppoletta, E. Mauro, E. Marturano, F. Crispi, A. Spadaro, A. Di Marco, and S. Leotta. "Defibrotide in Prevention of Liver Toxicity in Patients at High Risk of VOD after HSC Transplantation." Blood 112, no. 11 (November 16, 2008): 3275. http://dx.doi.org/10.1182/blood.v112.11.3275.3275.
Повний текст джерелаDignan, Fiona L., Dorothy Gujral, Mark E. Ethell, Jennifer Treleaven, Gareth Morgan, and Michael Potter. "Prophylactic Defibrotide in Allogeneic Stem Cell Transplantation: Low Morbidity and Zero Mortality from Veno-Occlusive Disease." Blood 108, no. 11 (November 16, 2006): 2968. http://dx.doi.org/10.1182/blood.v108.11.2968.2968.
Повний текст джерелаPescador, Rodolfo, Roberto Porta, and Laura Ferro. "Defibrotide and Endothelial Cell Activation." Cardiovascular Drug Reviews 18, no. 4 (June 7, 2006): 304–11. http://dx.doi.org/10.1111/j.1527-3466.2000.tb00054.x.
Повний текст джерела&NA;. "Defibrotide has benefits in AMI." Inpharma Weekly &NA;, no. 723 (February 1990): 8. http://dx.doi.org/10.2165/00128413-199007230-00019.
Повний текст джерелаRichardson, Paul G., Selim Corbacioglu, Vincent Trien-Vinh Ho, Nancy A. Kernan, Leslie Lehmann, Craig Maguire, Michelle Maglio, et al. "Drug safety evaluation of defibrotide." Expert Opinion on Drug Safety 12, no. 1 (December 10, 2012): 123–36. http://dx.doi.org/10.1517/14740338.2012.749855.
Повний текст джерелаLazarus, Hillard M., and Keith R. McCrae. "SOS! Defibrotide to the rescue." Blood 112, no. 10 (November 15, 2008): 3924–25. http://dx.doi.org/10.1182/blood-2008-09-177246.
Повний текст джерелаZhou, Quansheng, Xiaohong Chu, and Changgeng Ruan. "Defibrotide Stimulates Expression of Thrombomodulin in Human Endothelial Cells." Thrombosis and Haemostasis 71, no. 04 (1994): 507–10. http://dx.doi.org/10.1055/s-0038-1642468.
Повний текст джерела